Effects of Glucocorticoids on Subgingival Porphyromonas Gingivalis in Rats with Adriamycin-Induced Nephropathy

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (162 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: This paper aims to investigate the effect of glucocorticoid therapy on porphyromonas gingivalis(P.g) in subgingival plaque of rats with adriamycin-induced nephrotoxicity(ADR), and to realize the correlation between periodontitis nephrotic and glucocorticoid applications. Methods: 60 Wistar rats were randomly divided into two groups and normal group, and nephropathy group, 30 rats in each group. The rats in the nephropathy group were given 4 mg/kg adriamycin injection via tail vein to establish ADR model at the interval of 2 weeks. After the establishment of ADR model,the rats of the two groups were randomly selected 10 rats to be sacrificed and make the kidney pathological sections.Remaining 40 rats, 20 rats in the normal group were randomly divided into control group and glucocorticoids-treated group,10 rats in each group. Nephropathy group were divided into ADR group and ADR+glucocorticoids-treated group, 10 rats in each group. Glucocorticoids-treated group and ADR+glucocorticoids-treated group were given methylprednisolone 30 mg /(kg·d) for 10 weeks, control group and ADR group were given equal volume of normal saline. The subgingival plaque of rats was used to detect the detection rate and detection quantity of P.g in samples by using SYBR Green real-time quantitative PCR (qRT-PCR) technique. Results: The detection quantity of P.g in ADR+glucocorticoids-treated group was higher than that in other three groups (P<0.05), and the detection quantity of P.g in ADR group was higher than those in control group and glucocorticoids-treated group (P<0.05). The detection rates of P.g in control group and glucocorticoids-treated group were 40% and 50% respectively. The detection rate of P.g in ADR group and ADR+glucocorticoids-treated group was 90%, which was higher than that in control group and glucocorticoids-treated group (P<0.05). Conclusion: The level of P.g in rats was correlated with chronic kidney disease and the application of glucocorticoid,suggesting that the periodontal condition of ADR rats was affected by nephropathy and glucocorticoid therapy.

Key words： glucocorticoid nephrotic syndrome porphyromonas gingivalis qRT-PCR

Received: 20 February 2017

PACS:

R543.4

Fund:Tianjin Municipal Health Bureau Science and Technology Fund Project; grant number: 2014KZ095

Corresponding Authors: PENG Cheng. E-mail: peng_cheng2013@163.com

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GUO Le-le
	GUO Yi
	HOU Xiao-yan
	MA Ming
	LI Xiao-ying
	PENG Cheng

Cite this article:

GUO Le-le,GUO Yi,HOU Xiao-yan, et al. Effects of Glucocorticoids on Subgingival Porphyromonas Gingivalis in Rats with Adriamycin-Induced Nephropathy[J]. Chinese Journal of Biomedical Engineering, 2017, 26(2): 47-56.

URL:

http://manu32.magtech.com.cn/Jwk_zgswyx_en/EN/ OR http://manu32.magtech.com.cn/Jwk_zgswyx_en/EN/Y2017/V26/I2/47

[1] Phan V, Blydt-Hansen T, Feber J, et al. Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome[J]. Osteoporosis International, 2014,25(2):627-637.
[2] Leonard MB, Feldman HI, Shults J, et al. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome[J]. The New England Journal of Medicine, 2004,351(9):868-875.
[3] Tsampalieros A, Gupta P, Denburg MR, et al. Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome[J]. Journal of Bone and Mineral Research, 2013,28(3):480-488.
[4] Liang Y, Chen Y, Chen Y, et al. Role of the glucocorticoid receptor in the recurrence of primary nephrotic syndrome[J]. Experimental and Therapeutic Medicine, 2015,10(4):1556-1562.
[5] Rasch LA, Bultink IE, van Tuyl LH, et al. Glucocorticoid safety for treating rheumatoid arthritis[J]. Expert Opinion on Drug Safety, 2015,14(6):839-844.
[6] 乌·乌日娜，苏日古嘎，孙志强. 糖皮质激素药物系统应用的副作用及规避对策[J]. 中国医学文摘(皮肤科学), 2015, 32(3):248-252.
[7] Breivik T, Gundersen Y, Gjermo P, et al. Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis[J]. Journal of Periodontal Research, 2014,49(1):36-44.
[8] Reis C, Da CA, Guimaraes JT, et al. Clinical improvement following therapy for periodontitis: Association with a decrease in IL-1 and IL-6[J]. Experimental and Therapeutic Medicine, 2014,8(1):323-327.
[9] Baek KJ, Ji S, Kim YC, et al. Association of the invasion ability of Porphyromonas gingivalis with the severity of periodontitis[J]. Virulence, 2015,6(3):274-281.
[10] Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque[J]. Journal of Clinical Periodontology, 1998,25(2):134-144.
[11] Spooner R, Weigel KM, Harrison PL, et al. In situ anabolic activity of periodontal pathogens porphyromonas gingivalis and filifactor alocis in Chronic Periodontitis[J]. Scientific Reports, 2016,6:33638.
[12] Sanchez MC, Marin MJ, Figuero E, et al. Quantitative real-time PCR combined with propidium monoazide for the selective quantification of viable periodontal pathogens in an in vitro subgingival biofilm model[J]. Journal of Periodontal Research, 2014,49(1):20-28.
[13] Schmalz G, Tsigaras S, Rinke S, et al. Detection of five potentially periodontal pathogenic bacteria in peri-implant disease: A comparison of PCR and real-time PCR[J]. Diagnostic Microbiology and Infectious Disease, 2016,85(3):289-294.
[14] Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis[J]. Infection and Immunity, 1998,66(11):5337-5343.
[15] Dorn BR, Dunn WJ, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens[J]. Infection and Immunity, 1999,67(11):5792-5798.
[16] Takeuchi Y, Ishikawa H, Inada M, et al. Study of the oral microbial flora in patients with renal disease[J]. Nephrology (Carlton), 2007,12(2):182-190.
[17] Ismail FB, Ismail G, Dumitriu AS, et al. Identification of subgingival periodontal pathogens and association with the severity of periodontitis in patients with chronic kidney diseases: a cross-sectional study[J]. Biomed Research International, 2015,2015:370-314.
[18] Kurts C, Panzer U, Anders HJ, et al. The immune system and kidney disease: basic concepts and clinical implications[J]. Nature Reviews Immunology, 2013,13(10):738-753.
[19] Naugle K, Darby ML, Bauman DB, et al. The oral health status of individuals on renal dialysis[J]. Annals of Periodontology, 1998,3(1):197-205.
[20] Castillo A, Mesa F, Liebana J, et al. Periodontal and oral microbiological status of an adult population undergoing haemodialysis: a cross-sectional study[J]. Oral Diseases, 2007,13(2):198-205.
[21] Bastos JA, Diniz CG, Bastos MG, et al. Identification of periodontal pathogens and severity of periodontitis in patients with and without chronic kidney disease[J]. Archives of Oral Biology, 2011,56(8):804-811.
[22] Zhou X, Liu X, Li J, et al. Real-time PCR quantification of six periodontal pathogens in saliva samples from healthy young adults[J]. Clinical Oral Investigations, 2015,19(4):937-946.
[23] 袁杰，王少果，周建业，等. 慢性牙周炎唾液牙龈卟啉单胞菌的定量PCR检测[J]. 口腔医学研究, 2015,31(2):133-136.
[24] 邓淑丽，王颖，何佳燕，等. 实时荧光定量PCR法检测治疗后龈下菌斑中优势菌的变化[J]. 上海口腔医学, 2013,22(3):297-301.
[25] 李生娇，曹志中，周中华. 糖皮质激素对牙周炎发病作用的实验研究[J]. 临床口腔医学杂志, 2002,18(4):253-255.